Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PR3154 > IC16 RA > Flashcards

IC16 RA Flashcards

(53 cards)

Start Studying
1
Q

main goal of treatment

A

Achieve disease remission
- at least 6 months
- Boolean 2.0 criteria (remission)
- Index based classification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pharmacotherapy approach in RA

A
  • Glucocorticoid (ST use; bridging to DMARD)
  • DMARDs (LT use)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

non-pharmacological management strategies of RA

A
  • physical activity & exercise (avoid high-intensity weight-bearing)
  • PT/OT
  • healthy diet to reduce CV risk & inflammation e.g. fish oil,
  • weight management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is RA

A

Chronic autoimmune INFLAMMATORY systemic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prevalence of RA - age, gender

A
  • Can occur at any age, peak at 40-50 y/o
  • 3x more common in women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Genetic predisposition to RA

A
  1. HLA-DR1 or HLA-DR4 typing
  2. Parents are RF+
  3. Twin have RA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical presentation of RA (KEY FEATURES)

A
  • Inflammation (pain, swelling, redness, warmth)
  • Early Morning stiffness > 30 mins
  • Symmetrical polyarthritis
  • Systemic sx (fever, aching/stiffness, etc)
  • Extra-articular complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical presentation in CHRONIC RA

A
  • deformities
  • loss of physical fn & inability to carry out ADL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Radiologic finding - in late course of RA

A
  • Narrowing of joint space
  • Erosion (around margin of joint)
  • Hypertrophic synovial tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosis of RA

A

At least 4 of the following:
- Early Morning Stiffness >/= 1 hour for > 6 weeks
- Swelling of >/= 3 joints for > 6 weeks
- Swelling of wrist/ MCP/ PIP joints for > 6 weeks
- Rheumatoid nodules
- +ve RF and/or anti-CCP tests
- Radiographic changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lab findings for RA - all stages of RA

A
  • Autoantibodies (RF +ve, anti-CCP +ve)
  • Acute phase response (Incr ESR & incr CRP)
  • FBC (decr haematocrit, incr WBC & incr platelets)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of csDMARD

A
  • methotrexate
  • sulfasalazine
  • leflunomide
  • hydroxychloroquine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of tsDMARD (JAK inhibitor)

A
  • tofacitinib, baricitinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Examples of TNF-alpha inhibitor (bDMARD)

A

Etanercept, infliximab, adalimumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of IL6-receptor antagonist (bDMARD)

A

tocilizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of anti-CD20 B cell depleting monoclonal antibody (bDMARD)

A

rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why is glucocorticoid not recommended for LT use?

A

Side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Indication for glucocorticoid

A
  1. Low dose bridging therapy when initiating/changing csDMARD (for moderate-high disease activity)
  2. Low-dose continuous therapy for difficult to control patients (but not recommended)
  3. Control flares (up to 2-3 injection per joint/ yr, q3 months)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MOA of glucocorticoid

A

anti-inflammatory & immunosuppressive ppty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Side effects of glucocorticoid

A
  • osteoporosis, osteonecrosis
  • impaired glucose metabolism, insulin resistance, beta cell dysfunction
  • gastric ulcer (if concomitant NSAID)
  • incr CV risk
  • cataract, glaucoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Do DMARDs alter disease progression?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Onset of DMARDs

Study These Flashcards
A

Slow onset (weeks to months)

23
Q

When to adjust tx for DMARD

Study These Flashcards
A
  1. No improvement aft 3 months
  2. Target not reached aft 6 months
24
Q

Monitoring frequency active disease

Study These Flashcards
A

Every 1-3 months

25
DMARD therapy for moderate-severe RA disease activity
MTX + folic acid 5mg / week +/- short-term GC
26
Dose for glucocorticoid
PO prednisolone < 7.5mg/day
27
DMARD therapy for low RA disease activity
In order of preference: - Hydroxychloroquine (better tolerated) - Sulfasalazine (less immunosuppressive) - MTX (low cost) - Leflunomide
28
MTX dose (initiation, increment, target, max)
- Initiation: 7.5mg once weekly - Dose increment: 2.5-5mg every 4-12 wks based on response - Target: 15mg/week (within 4-6 wks of initiation) - Max dose: 25mg/week
29
MTX tablet strength
2.5mg
30
How long is GC added to DMARD for bridging
up to 3 months
31
Can GC be used in bDMARD/tsDMARD?
No
32
Renal/ liver dose adj: MTX
* AST/ALT > 3xULN: 75% of dose * CrCl < 50 ml/min: 50% of dose * CrCl < 30 ml/min: avoid use
33
Monitoring (sx & labs): MTX
Infection -like sx, jaundice, skin blisters; FBC, LFT (AST,ALT,albumin, bilirubin), SCr
34
csDMARD C/I pregnancy
MTX, leflunomide
35
Which csDMARD could cause retinopathy?
Hydroxychloroquine
36
Drugs to use when not at target with MTX
- Add bDMARD or tsDMARD (maximise improvements) or - Add Sulfasalazine & leflunomide (triple therapy; less adverse effects & lower cost)
37
Approach when patients with bDMARD/ tsDMARD but not at target
Switch to bDMARD or tsDMARD of a different class
38
General MOA of bDMARD
Binds to cytokine or their receptors to downregulate / inhibit their fn -> reduce immune & inflammatory responses
39
Administration route of bDMARD
SC inj/ IV infusion
40
Administration route of tsDMARD
Oral
41
C/I sulfasalazine
- sulfonamide allergy - G6pd deficiency
42
C/I hydroxychloroquine
- pre-existing retinopathy - g6pd deficiency
43
MOA of tsDMARD
Binds to JAK proteins inside cells to prevent JAKs from transphosphorylating the associated cytokine & growth factor receptor
44
JAK MEANING
Janus kinase (small molecule kinase)
45
-cept meaning
fusion of receptor to Fc region of IgG1
46
Which DMARDs cannot be used tgt
bDMARD and tsDMARD
47
Which DMARD to avid in HF (NYHA class III & IV)
TNF-alpha inhibitors
48
Anti-drug antibodies (ADA) may occur with ____, leading to loss of efficacy
TNF-𝛼 inhibitor
49
bDMARD or tsDMARD is preferred? why
bDMARD; tsDMARD more adverse effects (MACE, malignancy)
50
Pre-tx screening prior bDMARD/tsDMARD initiation
- TB - HepB & C
51
Vaccination required prior bDMARD/tsDMARD initiation
- Pneumococcal - Influenza - Hepatitis B - Varicella zoster
52
Lab screening/ monitoring prior starting ts/bDMARD
- CBC w differential white count & platelet count - LFT(ALT,AST,bilirubin,ALP) - Lipid panel - SCr
53
When is RA considered low disease activity or remission
patients at target for >/= 6 months

PR3154 (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions